Condition: Atrial Fibrillation
Location(s): St. Augustine
Condition: Atrial Fibrillation, Heart Disease
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Location(s): St. Augustine
Condition: Atrial Fibrillation, Heart Disease